Policy & Regulation
Kantaro Biosciences signs marketing agreement for COVID-SeroKlir and COVID-SeroIndex with EKF Diagnostics
29 October 2020 - Kantaro Biosciences LLC and its manufacturing partner Bio -Techne Corporation (NASDAQ:TECH ) on Wednesday entered into a two-year marketing and distribution agreement of its COVID-Se...
Agena Bioscience awarded FDA's EUA for high-throughput, low-cost SARS-CoV-2 panel
29 October 2020 - Genetic analysis systems company Agena Bioscience reported on Wednesday the receipt of the Emergency Use Authorization from the US Food and Drug Administration (FDA) for its MassARRA...
PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101
29 October 2020 - United States-based PeproMene Bio Inc has submitted an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) to study a novel chimeric an...
Samsung Biologics open's first US CDO R&D Centre in San Francisco
29 October 2020 - Samsung Biologics (KRX: 207940.KS), a publicly-traded biotechnology company, is opening its first US CDO (contract diagnostic organisation) R&D Centre in San Francisco, it was re...
Asieris Pharmaceuticals receives Australian regulatory authority approval for APL-1501 Phase I clinical trial
29 October 2020 - Asieris Pharmaceuticals, a China-based biotech company, has received approval for its Phase I clinical trial of APL-1501 from the Australian regulatory authorities, it was reported o...
Lubrizol Life Science Health launches ASTAGILE microcapsules with spirulina
29 October 2020 - Lubrizol Life Science Health (LLS), a Berkshire Hathaway Company, has introduced its ASTAGILE microcapsules, its new sustainable, organic-certified, astaxanthin (Haematococcus pluvia...
Related Headlines

Scholar Rock expects USD200m from public offering of common stock and prefunded warrants

Therapeutics Solution International Inc's JadiCell stem cells significantly increased survival of COVID-19 patients

COVID-19 vaccines free for all Americans that is authorised or approved by US FDA

Shionogi's CEO says Japanese COVID-19 vaccine ready for December trial

First Patient Received Investigational Gene Therapy GT005 Via Orbit Subretinal Delivery System in Ongoing Phase I/II FOCUS Trial

Enhertu Granted Priority Review in the US for Treatment of HER2 Positive Metastatic Gastric Cancer

Amgen Completes Discussions for Systemic Lupus Erythematosus Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs Pilot Program

AstraZeneca and Daiichi Sankyo's Enhertu granted FDA Priority Review for treatment of HER2-positive metastatic gastric cancer

European Trial Launched to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19

Biocom Purchasing Group Partners with Everlywell to Offer At-Home COVID-19 Testing and Lens Reporting Technology to Biocom Members

BC Platforms partners with CO-CONNECT Consortium to accelerate COVID-19 Research

Scholar Rock to launch USD150m common stock in public offering

IAVI, Merck and the US Department of Defense to accelerate development of vaccine candidate for COVID-19

Olatec Therapeutics admits first patients under Phase 2 COVID-19 clinical trial of Dapansutrile

Prilenia Enrolls First Patients Into its PROOF-HD Phase 3 Clinical Trial for Huntington's Disease in the United States